Yushiro Endo
- Immunology top 5%
- interferon and immune responses 6
- Complement system in diseases 6
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 8
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 7
- Blood Coagulation and Thrombosis Mechanisms 7
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research 9
- Rheumatoid Arthritis Research and Therapies 9
- Nephrology top 10%
-
- Inflammasome and immune disorders 13
- Co-authors
- Takamitsu SasakiGeorge C. TsokosHao LiAfroditi BoulougouraAtsushi KawakamiYutaka YonemuraK MiyaiTomohiro Koga
- Cited by
- ImmunologyCancer ResearchHematology
- Journals
- SHILAP Revista de lepidopterología (3 papers)The EMBO Journal (2 papers)Blood (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Yushiro Endo
97 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 104
- Immunology 500
- Cancer Research 232
- Hematology 168
- Rheumatology 214
- Nephrology 81
Countries citing papers authored by Yushiro Endo
This map shows the geographic impact of Yushiro Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yushiro Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yushiro Endo more than expected).
Fields of papers citing papers by Yushiro Endo
This network shows the impact of papers produced by Yushiro Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yushiro Endo. The network helps show where Yushiro Endo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yushiro Endo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 1 | |
| 6 | The possession of exon 2 or exon 3 variants in the MEFV gene promotes inflammasome activation in Japanese patients with familial Mediterranean fever with a heterozygous exon 10 mutation. | 2020 | 8 |
| 7 | 2020 | 18 | |
| 8 | 2011 | 14 | |
| 9 | 2003 | 16 | |
| 10 | [Non-approved antidotes in Japan--Foreign antidotes imported for poisoning countermeasures at the Summit 2000]. | 2001 | 1 |
| 11 | 2001 | 34 | |
| 12 | 1999 | 4 | |
| 13 | 1998 | 71 | |
| 14 | 1996 | 40 | |
| 15 | Immunoserologically diagnosed toxocariasis with bilateral pleural effusion | 1995 | 1 |
| 16 | 1994 | 7 | |
| 17 | 1993 | 7 | |
| 18 | 1993 | 3 | |
| 19 | [In vitro chemosensitivity test using collagen gel matrix for human gastric carcinomas]. | 1991 | 2 |
| 20 | Experimental study of PMX-F on its effect and biocompatibility. | 1985 | 1 |
About Yushiro Endo
Yushiro Endo is a scholar working on Rheumatology, Hematology and Immunology, having authored 99 papers that have together received 1.4k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (13 papers), Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (9 papers), Protease and Inhibitor Mechanisms (8 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), interferon and immune responses (6 papers) and Complement system in diseases (6 papers). The work is most often cited by research in Immunology (500 citations), Cancer Research (232 citations) and Hematology (168 citations). Yushiro Endo has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Takamitsu Sasaki, George C. Tsokos, Hao Li, Afroditi Boulougoura, Atsushi Kawakami, Yutaka Yonemura, K Miyai, Tomohiro Koga, Yoshihide Hayashizaki and Yuji Hiraoka. Their work appears in journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.